Bio markers predict invasive cancer?
Has anyone heard about this test? Interesting.
http://www.cbsnews.com/stories/2010/04/28/eveningnews/main6441729.shtml
A new test was announced by the University of California, San Francisco. It analyzes certain characteristics of biopsied breast tissue -- called biomarkers -- to predict which women with DCIS are more likely to develop invasive cancer over eight years.
To see who is most at risk, researchers followed more than 1,100 women with DCIS, treated with a lumpectomy alone. The highest-risk women had about a 20 percent chance. The lowest risk patients had less than a 5 percent chance -- only slightly more than that of an average 60-year-old woman.
"What these markers allow the women and clinician to do, is to stratify risk- to identify that woman who has a high probability of having a future tumor so that she can chose an aggressive treatment," Tlsty said.
This new test could also spare women at lowest risk from an aggressive treatment they don't need.
Comments
-
also interesting
http://www.cbsnews.com/video/watch/?id=6443529n
http://www.uphs.upenn.edu/news/News_Releases/2009/05/dcis-her2-breast-cancer-risk.html
Pathologists do not currently examine DCIS for HER2 expression because it does not impact treatment. However, given these new data, Czerniecki thinks it may be appropriate for clincians to change their approach in the future. The data also suggest that HER2/neu overexpression may be critical for the transition from in situ disease to invasive disease, Czerniecki says. "If HER2 is associated with invasion or plays a role in the development of invasive disease, then maybe targeting it early can keep people from moving from DCIS to invasive cancer."
another good link http://www.uphs.upenn.edu/news/News_Releases/2009/05/dcis-her2-breast-cancer-risk.html
-
http://www.uphs.upenn.edu/news/News_Releases/2009/05/dcis-her2-breast-cancer-risk.html
Wed Apr 28, 7:03 pm ET
WEDNESDAY, April 28 (HealthDay News) -- A new way to predict whether women with the most common form of breast cancer are at risk of developing more invasive tumors later in life will help those women be more selective about their treatment, U.S. researchers report.
They analyzed the medical records of 1,162 women, aged 40 and older, who were diagnosed with ductal carcinoma in situ (DCIS) and underwent lumpectomy, which is surgical removal of the tumor and some of the surrounding normal tissue.
The researchers found that two factors -- method of diagnosis and expression of several biomarkers -- were predictors of the risk of developing invasive breast cancer within eight years of being diagnosed with DCIS.
The risk was higher among women who had a breast lump diagnosed as DCIS than among those whose DCIS was diagnosed by mammography. Women with high levels of the biomarkers p16, cyclooxygenase-2, and Ki67 in DCIS tissue were also more likely to develop invasive breast cancer.
Women with the lowest risk had only a 2 percent chance of developing invasive breast cancer at five years after diagnosis and a 4 percent chance at eight years.
As a result of the research, doctors can better predict whether women treated with a lumpectomy only are at a very low or a high risk of developing invasive cancer later.
The findings mean that women with DCIS "will have much more information, so they can better know their risk of developing invasive cancer. It will lead to a more personalized approach to treatment. As many as 44 percent of patients with DCIS may not require any further treatment, and can rely instead on surveillance," study author Dr. Karla Kerlikowske, a professor of medicine, and epidemiology and biostatistics at the University of California, San Francisco Helen Diller Comprehensive Cancer Center, said in a news release.
Only about 1 percent to 2 percent of women with DCIS die of breast cancer within 10 years of diagnosis, but many choose aggressive treatment because they don't fully understand their risk of developing invasive breast cancer, the researchers said.
The study appears online April 28 in the Journal of the National Cancer Institute.
-
Such tests may eliminate unneeded aggressive dcis breast cancer treatments. I am thrilled that such a test will soon be available.
-
wow, that is interesting. I found my dcis because I had a lump.
-
MY DCIS was found on mammo- microcalcifications. I'm scheduled for a lumpectomy this coming Monday. I'm also having intraoperative radiation therapy (IORT) during lumpectomy.
-
mom3band1g; maybe you should ask if you can get the full panel on biomarkers on your path report...might not hurt and may help in the future....sorry you are in this group! My margins were tight and grade 3 and under 44 so I know how that feels!
-
I think I will call my surgeon Monday!
-
I would suggest reading the accompanying editorial in th Journal of the National Cancer Institute as well. It points out this study is very preliminary and the results will need to be validated before changing clinical practice. Also it's worthwhile thinking about how this test might, or might not, change anyone's specific treatment In the case of mom3band1g, for example, she is already proactively doing everything there is to do: bilateral mastectomy and radiation. I think the implications are more to identify a cohort of women with DCIS who might need no further treatment other than lumpectomy. Anyway, here's the editorial link:
-
I agree with dsj: the study is a retroactive study in that they looked at data collected on women treated from 1983 to 1994 with only a lumpectomy. They used this data to see which of the women had a recurrence. From that they were able to show that women with a certain "formula" of biomarkers were more likely to recur. They even state that it is too early to form any concrete conclusions at this point, however, I still think it would be a good idea to gather the info from the sample. This research may lead to future predictions for untreated DCIS as well as those of us who have had a BMX. Recurrance following mastectomy is thought to be from cells left behind from the surgeon or an invasive component that was not identified. Even with a 1 - 2% recurrance rate, you still worry. Personally I would have liked to have this information so that I could either a: not worry as much or b: make sure I had appropriate follow up care. I don't know if it is too late now that all of my samples are engulfed in parafin archived away in the lab. Just assuming it would be easier and more cost effective to do it at the time of initial lab tests.
-
I'm due for my 6 month mammo, and in my upcoming bc doctor appointment, I'm going to ask for a HER2 test. If I do have a HER2 protein, I will consider a double mx so not to be concerned about bc invasive cancer. I never thought I would say this, but watchful waiting (if you are high risk with HER2) is waiting for the shoe to drop. If I am not HER 2, hey, I'm comfortable with watchful waiting.
If I remember right, my bc surgeons said that they don't usually do the test unless you are dx with invasive cancer. Every dcis patient should have the test. It is my opinion that we need to know everything about our risks, options and like Deirdre says, couseling. When I was first dx with dcis it was a whirlwind. Surgery happened 3 weeks within dx. There wasn't much time for homework. I dug my heels in soon after first dx and said, hold it.. I wanted to make an intelligent choice, to be a part of the process. I'm not afraid anymore to speak my mind, and to ask for such a test.
-
ebarry, the problem with HER2 testing for DCIS patients is that a lot of us will turn out to be HER2+. And then what? The fact is that a much higher percent of DCIS patients are HER2+ (about 40%) versus those who have IDC (about 20% are HER2+). No one knows yet why that is. And whether HER2 status is an indicator of aggressiveness and future invasion isn't known yet either. The study that you linked from last year is the most recent study on this, and it did show that those who were HER2+ had a higher risk of invasion, but there have been other studies that have shown just the opposite. All these studies are small, so at this point there really is no definitive answer, just conflicting information. Even the author of the study that you linked isn't saying anything definitive: "If HER2 is associated with invasion or plays a role in the development of invasive disease, then maybe targeting it early can keep people from moving from DCIS to invasive cancer." It sounds like it's just a hypothesis at this point, not a known or certain fact.
Here are other studies on HER2 status and DCIS:
http://cebp.aacrjournals.org/content/11/6/587.full This one found that "HER-2/neu gene amplification was less common in DCIS associated with invasive breast cancer (cases) than DCIS alone (controls). "
http://journals.lww.com/oncology-times/Fulltext/2007/04250/Importance_of_HER_2_Neu_Positivity_as_Predictor_of.16.aspx This article reviews two research studies on HER2 status & DCIS that each came to different conclusions. "The first suggested that HER-2/neu overexpression was a predictor of invasive recurrence, and the second study said it was not predictive of outcome."
So it's fifty/fifty at this point - half the studies say that HER2+ status is an indicator of future invasion, and half say it's not. With this information, or more to the point, lack of information, in the end we all have to do what we are comfortable with. In my case, I don't know my HER2 status. I'm glad. I'm not comfortable that medical science knows much at all about what it means and what should be done (if anything at all) for those who have HER2+ DCIS. So knowing my HER2 status would only confuse me and possibly concern me.
-
Beesie, Thanks, I looked over the links. I like many, hope that science will find a link between non-invasive and invasive cancer. I do not want a mx, and if knowing that HER2 protein will not be the tell all answer, I'm again back to square one. I can handle another dcis dx...just do not want to deal with invasive cancer.
I fully realize I am high risk for another recurrence. From what I learned on the boards I know that I have a 50% chance for a recurrence. I got excited thinking that the HER2 might perhaps be negative and give me the assurance I am on the right track or/and if it is positive, give me the reason to be a little more aggressive.
-
When you say you have a 50% chance of recurrence, what do you mean? If someone diagnosed with DCIS has a recurrence, there's a 50% chance that recurrence will be invasive. But it's 50% of what your own risk is. So if your risk of recurrence is, for example, 5%, your risk of invasive cancer is 2.5%
An overall 50% chance of recurrence is very, very high. If you indeed have an overall 50% chance I would imagine the BS would have urged a mastectomy from the start.
-
dsj...ok...maybe I'm confused. I thought that I read somewhere on the boards 50% of all high grade had a 50% recurrence rate.
You are right...it is 50% recurrence is invasive. Lately I've been crazy thinking that my chance for a recurrence rate was about 50%. Hopefully it's less!
.I already had one recurrence, within a years time. My second bc surgeon said next time I had to get more serious and consider a mx. At my first dx, I thought, since dcis is not invasive, just cutting out the bad spot would take care of it. The next year, I had a recurrence which was multifocal. I chose not to have a mx due to $$$ . Instead I tried naturalpathic medicine, which I've done this past year... I am taking supplements and working on my diet to prevent future recurrence.
To add, I've never seen a oncologist...just b.c. surgeon and one interview with a rad doc. I've done my own research, coming here and there to help me find my way. Thanks for being candid.
-
Rate for recurrence in lumpectomy with radiation is 11%, without radiation 22%, depending upon risk factors. Half of that can be invasive. So realistically, your max risk is 11% or less for having it come back and it is invasive. This statistic is from this webpage: http://www.cancer.gov/clinicaltrials/results/DCIS0309. Sorry that you thought that ebarry! Boy I would have been beside myself! The recurrance rate following a mastectomy is 1 to 2%.
-
The 11% recurrence rate with radiation and 22% recurrence rate without radiation are averages for that particular group of 3,900 women, with all the different pathologies and margins that they had. Those are good averages but it's important to remember that an individual's risk can vary considerably from this, depending on the pathology. Shortly after I was diagnosed I recall reading one report that indicated that recurrence risk after a lumpectomy for DCIS, without radiation, can be as low as 4% for those who have small (<1cm) low grade tumors and good margins, and as high as 60% for those who have large high grade tumors and small margins. I wish I could find that article - it was really detailed and good - but I can't. However, the tables in this website show recurrence risks similar to that: http://theoncologist.alphamedpress.org/cgi/content/full/3/2/94/T2
The following article mentions 2 different studies that compare recurrence rates for women with DCIS who had or didn't have radiation. Again, these recurrence rates represent the average for all the women in the study, with all their different types of pathology. The recurrence rates here are slightly higher than those quoted in the other NCI article: http://www.cancer.gov/cancertopics/pdq/treatment/breast/HealthProfessional/page5
- The results of NSABP-B17 were that "(a)t the 12-year actuarial follow-up interval, the overall rate of in-breast tumor recurrence was reduced from 31.7% to 15.7% when radiation therapy was delivered. Radiation therapy reduced the occurrence of invasive cancer from 16.8% to 7.7% and recurrent DCIS from 14.6% to 8.0%."
- The results of the EORTC-10853 trial were that "(a)t a median follow-up of 10.5 years, the overall rate of in-breast tumor recurrence was reduced from 26% to 15% with a similarly effective reduction of invasive (13% to 8%) and noninvasive (14% to 7%) recurrence rates."
ebarry, this isn't to worry you but simply to point out that recurrence risk can vary a lot and there is no way to know what yours is without talking to your doctors, and preferably, to an oncologist, about your specific pathology.
-
Thanks Beesie...I've seen these stats sometime ago...forget. In January 2008 my appointment with a rad/oncologist said that most women who had rads only had a 5% advantage over someone who didn't have rads. I thought I could handle the 5%. I falsely hoped that my odds for a recurrence was low.
The first link you sent puts me at 22% risk for surgery only, and 39%/margins in eight years...although my last bc margin was .03. I'm not sure if that is average margin for excision only. I suppose my risk is high for a recurrence? Since my cancer was high grade, I'm not sure my odds are good.
I'm concerned. I'm doing a little more thinking and research about bc cancer recurrence & mx before my upcoming mammo and bc doctor appointment in late May or early June. There are no easy answers.
-
Even though I am supposed to do rads....I am nervous. One of my margins was 1mm and the other less than 1mm. I keep telling mysefl that with time the fear will fade. Honestly, I don't want to do rads at all.
I am wondering though..my lumpectomy (on my palpable lump) path showed comdonecrosis and grade 3. The path on my mast showed noncomdo necrosis grade 2 and 3. Would that mean the most aggrsive DCIS was in my actual lump and because I then had a mast the worst was gone? Although one of my bad margins was in that area. Ok, I'm chasing my own tail.
This stuff could drive you absolutely crazy.
-
ebarry, when the radiation oncologist said to you that "most women who had rads only had a 5% advantage over someone who didn't have rads." he probably was thinking in terms of all women with DCIS (all diagnoses) and an average recurrence risk, pre-radiation, of about 10%. Rads cut recurrence risk by 50% - lots of studies have shown that - so if the starting risk is 10%, then those who take rads will reduce their risk by 50%, i.e. by 5 points to 5%. But, if someone has a 30% risk of recurrence prior to radiation, then rads will reduce this risk by 15 points to 15%.
In terms of your risk, only your doctor can tell you what it is. Based on what you've said about your pathology - the fact that your DCIS was high grade, the fact that you had a recurrence after initially having good margins & that you've mentioned that in some places in your pathology there were 3mm spaces between areas of DCIS (both of which suggest that your DCIS "skips" and/or was multifocal) and the fact that you had at least one margin that was no greater than 3mm (which is considered by many surgeons to about the smallest "acceptable" margin) - I would guess that your recurrence risk is quite high, probably in the 30% - 40% range. That's not to scare you but just my assessment based on everything I've read. But remember that this is just the guess of patient with no medical background, so I could easily be wrong. If you are worried, you really need to get a professional opinion about this - preferrably from an oncologist. And keep in mind that even if I'm right, the odds are still probably greater than you won't have a recurrence than that you will.
mom3band1g, your pathology sounds like mine. I had a lot of DCIS, just like you. Most of it was grade 3 with comedonecrosis but around the edges there was some grade 2 without comedonecrosis. My microinvasion was right in the middle, in the area where the pathology was most aggressive. From what you've said my guess is that most of the DCIS near your margins was probably not as aggressive as the DCIS in your lump. That would be good. And in any case, you are having radiation, which will cut your risk in half. Yes, it's normal to worry - it actually would be strange if you didn't worry - but it should fade in time. For most of us, it does.
-
mom3band1g, I know everyone's experience is different, but in my case I have finished 17 of 25 zaps and have had no side-effects whatsoever. No redness, no irritation, no swelling. Nothing. And I am having a concurrent boost every day. I have my fingers crossed, but apparently some peope do sail through it.
What exactly are you afraid of? Sometimes it helps me to try to articulate my fear and go from there.
I know from having read your earlier posts, that deciding to have a bilateral mastectomy was hard for you. But you did go through with that decision and choose to be very proactive. So I'm guessing a recurrence is a big fear as well. In the end, which is the scarier? (sort of a rhetorical question I know
)
Categories
- All Categories
- 679 Advocacy and Fund-Raising
- 289 Advocacy
- 68 I've Donated to Breastcancer.org in honor of....
- Test
- 322 Walks, Runs and Fundraising Events for Breastcancer.org
- 5.6K Community Connections
- 282 Middle Age 40-60(ish) Years Old With Breast Cancer
- 53 Australians and New Zealanders Affected by Breast Cancer
- 208 Black Women or Men With Breast Cancer
- 684 Canadians Affected by Breast Cancer
- 1.5K Caring for Someone with Breast cancer
- 455 Caring for Someone with Stage IV or Mets
- 260 High Risk of Recurrence or Second Breast Cancer
- 22 International, Non-English Speakers With Breast Cancer
- 16 Latinas/Hispanics With Breast Cancer
- 189 LGBTQA+ With Breast Cancer
- 152 May Their Memory Live On
- 85 Member Matchup & Virtual Support Meetups
- 375 Members by Location
- 291 Older Than 60 Years Old With Breast Cancer
- 177 Singles With Breast Cancer
- 869 Young With Breast Cancer
- 50.4K Connecting With Others Who Have a Similar Diagnosis
- 204 Breast Cancer with Another Diagnosis or Comorbidity
- 4K DCIS (Ductal Carcinoma In Situ)
- 79 DCIS plus HER2-positive Microinvasion
- 529 Genetic Testing
- 2.2K HER2+ (Positive) Breast Cancer
- 1.5K IBC (Inflammatory Breast Cancer)
- 3.4K IDC (Invasive Ductal Carcinoma)
- 1.5K ILC (Invasive Lobular Carcinoma)
- 999 Just Diagnosed With a Recurrence or Metastasis
- 652 LCIS (Lobular Carcinoma In Situ)
- 193 Less Common Types of Breast Cancer
- 252 Male Breast Cancer
- 86 Mixed Type Breast Cancer
- 3.1K Not Diagnosed With a Recurrence or Metastases but Concerned
- 189 Palliative Therapy/Hospice Care
- 488 Second or Third Breast Cancer
- 1.2K Stage I Breast Cancer
- 313 Stage II Breast Cancer
- 3.8K Stage III Breast Cancer
- 2.5K Triple-Negative Breast Cancer
- 13.1K Day-to-Day Matters
- 132 All things COVID-19 or coronavirus
- 87 BCO Free-Cycle: Give or Trade Items Related to Breast Cancer
- 5.9K Clinical Trials, Research News, Podcasts, and Study Results
- 86 Coping with Holidays, Special Days and Anniversaries
- 828 Employment, Insurance, and Other Financial Issues
- 101 Family and Family Planning Matters
- Family Issues for Those Who Have Breast Cancer
- 26 Furry friends
- 1.8K Humor and Games
- 1.6K Mental Health: Because Cancer Doesn't Just Affect Your Breasts
- 706 Recipe Swap for Healthy Living
- 704 Recommend Your Resources
- 171 Sex & Relationship Matters
- 9 The Political Corner
- 874 Working on Your Fitness
- 4.5K Moving On & Finding Inspiration After Breast Cancer
- 394 Bonded by Breast Cancer
- 3.1K Life After Breast Cancer
- 806 Prayers and Spiritual Support
- 285 Who or What Inspires You?
- 28.7K Not Diagnosed But Concerned
- 1K Benign Breast Conditions
- 2.3K High Risk for Breast Cancer
- 18K Not Diagnosed But Worried
- 7.4K Waiting for Test Results
- 603 Site News and Announcements
- 560 Comments, Suggestions, Feature Requests
- 39 Mod Announcements, Breastcancer.org News, Blog Entries, Podcasts
- 4 Survey, Interview and Participant Requests: Need your Help!
- 61.9K Tests, Treatments & Side Effects
- 586 Alternative Medicine
- 255 Bone Health and Bone Loss
- 11.4K Breast Reconstruction
- 7.9K Chemotherapy - Before, During, and After
- 2.7K Complementary and Holistic Medicine and Treatment
- 775 Diagnosed and Waiting for Test Results
- 7.8K Hormonal Therapy - Before, During, and After
- 50 Immunotherapy - Before, During, and After
- 7.4K Just Diagnosed
- 1.4K Living Without Reconstruction After a Mastectomy
- 5.2K Lymphedema
- 3.6K Managing Side Effects of Breast Cancer and Its Treatment
- 591 Pain
- 3.9K Radiation Therapy - Before, During, and After
- 8.4K Surgery - Before, During, and After
- 109 Welcome to Breastcancer.org
- 98 Acknowledging and honoring our Community
- 11 Info & Resources for New Patients & Members From the Team